November 2009 - IOZK

Strong CD8(+) T-cell responses against tumor-associated antigens prolong the recurrence-free interval after tumor treatment in patients with hepatocellular carcinoma

2009-11-20/in Hepatocellular Carcinoma, International Publications /von 2009-11-20 / J. Gastroenterol. 2010 Apr;45(4):451-8

Comparison of monocyte-derived dendritic cells from colorectal cancer patients, non-small-cell-lung-cancer patients and healthy donors

2009-11-04/in Dendritic Cells, International Publications /von 2009-11-04 / Vaccine 2009 Dec;28(2):542-7

[Dendritic cell vaccine for intrahepatic cholangio cellular carcinoma–a study of relationship between immuno-reaction and clinical outcome]

2009-11-01/in Dendritic Cells, Gallbladder Cancer, International Publications /von 2009-11-01 / Gan To Kagaku Ryoho 2009 Nov;36(12):1964-6

[The case of tumor escape mechanism by changing their tumor-associated antigens]

2009-11-01/in Dendritic Cells, Gallbladder Cancer, International Publications /von 2009-11-01 / Gan To Kagaku Ryoho 2009 Nov;36(12):1988-90

Heat-shock protein vaccines as active immunotherapy against human gliomas

2009-11-01/in Dendritic Cells, Glioblastoma, Hyperthermia, International Publications /von 2009-11-01 / Expert Rev Anticancer Ther 2009 Nov;9(11):1577-82

Quadrimodal treatment of high-risk T1 and T2 bladder cancer: transurethral tumor resection followed by concurrent radiochemotherapy and regional deep hyperthermia

2009-11-01/in Hyperthermia, International Publications /von 2009-11-01 / Radiother Oncol 2009 Nov;93(2):358-63

Immune responses in patients with metastatic renal cell carcinoma treated with dendritic cells pulsed with tumor lysate

2009-11-01/in Hypernephroma, International Publications /von 2009-11-01 / Scand. J. Immunol. 2009 Nov;70(5):481-9